Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
Authors:
Open Access
- 1 May 2020
- journal article
- Published by Elsevier in HeartRhythm Case Reports
- Vol. 6 (5) , 241-243
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Chloroquine and hydroxychloroquine as available weapons to fight COVID-19International Journal of Antimicrobial Agents, 2020
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Clinical Infectious Diseases, 2020
- Chloroquine for the 2019 novel coronavirus SARS-CoV-2International Journal of Antimicrobial Agents, 2020
- Suspected Hydroxychloroquine-Associated QT-Interval Prolongation in a Patient With Systemic Lupus ErythematosusJCR: Journal of Clinical Rheumatology, 2013
- Conduction disorder and QT prolongation secondary to long-term treatment with chloroquineInternational Journal of Cardiology, 2008
- Azithromycin-induced QT prolongation in elderly patient.2006
- Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular ArrhythmiaClinical Toxicology, 2006
- A case of QT-interval prolongation precipitated by azithromycin.2003
- Drug induced QT prolongation and torsades de pointesHeart, 2003
- QT Prolongation Associated with Azithromycin/Amiodarone CombinationPacing and Clinical Electrophysiology, 2001